Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001079973-20-000063
Filing Date
2020-01-27
Accepted
2020-01-27 16:27:06
Documents
1
Group Members
IBEX GP LLCIBEX INVESTMENT HOLDINGS II LLCIBEX INVESTMENT HOLDINGS LLCIBEX ISRAEL FUND LLLPJUSTIN B. BORUS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A ibex_13ga-redhill.htm SC 13G/A 143036
  Complete submission text file 0001079973-20-000063.txt   144787
Mailing Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209
Business Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209 303-500-8821
Ibex Investors LLC (Filed by) CIK: 0001531964 (see all company filings)

EIN.: 331042318 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Subject) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SC 13G/A | Act: 34 | File No.: 005-87280 | Film No.: 20549838
SIC: 2834 Pharmaceutical Preparations